Cloudbreak Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	15.09	34.86	52.65	15.92
Short-Term Investments	-	-	7.5	63.19
Cash & Short-Term Investments	15.09	34.86	60.15	79.11
Cash Growth	-80.93%	-42.05%	-23.96%	-
Other Receivables	0.32	2.09	0.77	0.81
Receivables	0.32	2.09	0.77	0.81
Prepaid Expenses	7.01	0.05	0.17	0.18
Other Current Assets	-	0.51	0.37	0.01
Total Current Assets	22.42	37.51	61.47	80.11
Property, Plant & Equipment	2.24	2.43	3.27	1.17
Other Long-Term Assets	1.08	0.07	0.1	0.81
Total Assets	25.74	40.01	64.83	82.09
Accounts Payable	3.15	1.76	2.1	1.23
Accrued Expenses	1.83	2.06	1.72	1.85
Short-Term Debt	347.73	386.2	322.46	109.96
Current Portion of Leases	0.23	0.3	0.32	0.29
Current Income Taxes Payable	0.09	0.08	0.02	-
Other Current Liabilities	2.76	0.95	0.78	113.38
Total Current Liabilities	355.79	391.35	327.4	226.7
Long-Term Leases	0.12	0.21	0.23	0.55
Total Liabilities	355.91	391.56	327.63	227.25
Common Stock	0.05	0.05	0.05	0.05
Additional Paid-In Capital	-	258.28	258.28	258.28
Retained Earnings	-330.22	-344.25	-245.12	-115.7
Comprehensive Income & Other	-	-265.62	-276	-287.79
Shareholders' Equity	-330.17	-351.55	-262.79	-145.16
Total Liabilities & Equity	25.74	40.01	64.83	82.09
Total Debt	348.08	386.71	323	110.8
Net Cash (Debt)	-332.99	-351.84	-262.85	-31.69
Net Cash Per Share	-0.70	-0.74	-0.57	-0.07
Filing Date Shares Outstanding	475.39	475.39	462.54	458.6
Total Common Shares Outstanding	475.39	475.39	462.54	458.6
Working Capital	-333.37	-353.84	-265.93	-146.59
Book Value Per Share	-0.69	-0.74	-0.57	-0.32
Tangible Book Value	-330.17	-351.55	-262.79	-145.16
Tangible Book Value Per Share	-0.69	-0.74	-0.57	-0.32
Machinery	-	0.84	0.75	0.36
Leasehold Improvements	-	1.04	1.01	0.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.